ABSTRACT
Understanding Disease? .................................................................... 379 18.1.2 Eroom’s Law → Moore’s Law in Reverse? .......................................380 18.1.3 Merging of In Silico, In Vitro, In Vivo → In Proto? ......................... 381
18.2 Technological Considerations ....................................................................... 382 18.2.1 Cell Source ....................................................................................... 383
18.2.1.1 Induced Pluripotent Stem Cells ......................................... 383 18.2.1.2 Autologous Adult Stem Cells .............................................384 18.2.1.3 Autologous Cancer Cells ....................................................384
